BRIEF — Santhera Pharmaceuticals H1 Operating Income CHF — 6.562 Million

Sep 30 (Reuters) — Santhera Pharmaceuticals H1 operating expenses CHF -25.007 million. H1 net income CHF -21.526 million H1 EPS CHF -1.5